Cipla & Pharma Stocks Surge on US Drug Price News

  Published 1 year ago

Cipla shares are rising, mirroring gains in the pharma sector, fueled by reports the US has exempted generic drugs from planned price cuts. This news from Reuters is boosting investor confidence.

  • Cipla stock is trading higher today.
  • US exempts generics from price cuts.
  • Positive outlook for pharma companies.

You might like these

India to Source 10% Cooking Gas from US by 2026

SBI Life’s Strong H1 FY26 Growth

Wockhardt’s Zaynich Shows Breakthrough

E2E Networks Wins ₹177 Cr GPU Deal

Trump Tariffs Hit European Chipmakers

M&B Engineering Q1 Surge & IPO

India to Manufacture SURYA Launcher

News that matters the most ⚡